In this session Dr. Chopra, a world renowned hepatologist, thinker, inspirational speaker and bestselling author will simulate commonly posed curbside and email questions to a hepatologist from a primary care clinician. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 9, 2020, and they are subject to change as new information is published.
This session will review the geographical distribution of people at risk for developing celiac disease and populations that should undergo screening for celiac disease. The faculty will describe the changing presentations of celiac disease, review the gastroenterological and extraintestinal manifestations (such as irritable bowel disease), and emphasize the importance of a gluten free diet as an integral component to successful remission. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on Feb 9, 2020, and they are subject to change as new information is published.
Join this lecture for an overview of the pathophysiology, evaluation, and management of patients with nonalcoholic fatty liver disease. The faculty will review current concepts, disease progression, and therapeutics. You will learn about surgical treatments and their impact in patients with nonalcoholic steatohepatitis and obesity as well as the risk for hepatocellular carcinoma.
This talk will discuss the appropriate use of PPIs, including FDA indications and other accepted uses based on guidelines and systematic reviews. There will also be a brief review of the literature regarding issues of PPI safety. While many retrospective studies have raised concerns about various health conditions associated with PPI use, the quality of these studies need to be accounted for when considering the potential benefit that can be derived from these medications, even with long-term use. Finally, the faculty will provide a summary of “best practices."
This presentation will use case-based scenarios to illustrate different patterns of liver test abnormalities. The faculty will discuss the difference between cholestatic versus hepatitis versus infiltrative liver diseases and their characteristic liver test patterns. You will learn about the workup of liver test abnormalities with subsequent supplemental serological testing, imaging, and in some cases, liver biopsy. After this session, you will know the difference between true “liver function tests,” tests of cholestasis, tests of inflammation, and tests of infiltration.
Advanced GI dietitian Bethany Doerfler and GI Health Psychologist Sarah Quinton guide you through nutrition and lifestyle trends related to food intolerances, food allergies and GI health in 2020. Critical differences exist between food intolerances and IgE food allergies or Celiac disease. Consumers are often overwhelmed but interested in the role of dietary manipulation on GI health. This talk will focus on data surrounding the accuracy of testing, recommended diet and lifestyle therapy, and the impact of diet on eating behaviors and quality of life. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 11/14/2020, and they are subject to change as new information is published.
Guest: Robert Baldor, MD, FAAFP Music Credit: Richard Onorato
Heartburn is a frequent complaint in primary care practices. The etiology is broad, from reflux to H. pylori infection and PUD. While many clinicians treat symptomatically, this may not lead to patient satisfaction. A recent network meta-analysis published in The BMJ, concluded that a ‘test and treat’ approach resulted in the lowest reports for patients to remain symptomatic at follow-up.
Getting Glutened: Early Childhood Gluten Consumption and the Risk of Celiac Disease - Frankly Speaking EP 144
Guest: Alan Ehrlich MD, FAAFPMusic Credit: Richard Onorato
The degree to which early exposure to gluten-containing foods affects the risk of developing celiac disease is controversial. Join us as we discuss a recent Norwegian study suggesting that the timing of introduction of gluten in the diet may be less important than the amount of gluten in the diet at 18 months of age.